دورية أكاديمية
Beyond Wrinkles: A Comprehensive Review of the Uses of Botulinum Toxin.
| العنوان: | Beyond Wrinkles: A Comprehensive Review of the Uses of Botulinum Toxin. |
|---|---|
| المؤلفون: | Coetzee S, Nunez N, Belaunzaran M, Mark J, Stickler MA |
| المصدر: | Journal of drugs in dermatology : JDD [J Drugs Dermatol] 2023 Sep 01; Vol. 22 (9), pp. 7243e. |
| نوع المنشور: | Journal Article; Review; Systematic Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Physicians Continuing Education Corporation Country of Publication: United States NLM ID: 101160020 Publication Model: Print Cited Medium: Internet ISSN: 1545-9616 (Print) Linking ISSN: 15459616 NLM ISO Abbreviation: J Drugs Dermatol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: <2007- > : New York, NY : Physicians Continuing Education Corporation Original Publication: New York, NY : Strategic Communication in Dermatology |
| مواضيع طبية MeSH: | Botulinum Toxins*/adverse effects , Cardiovascular Diseases* , Ophthalmology*, Humans ; Esthetics ; Neurotoxins/therapeutic use ; United States |
| مستخلص: | Background: Botulinum neurotoxin (BoNT) exhibits inhibitory effects on the neuromuscular junction, and its use is well established in cosmetic dermatology. Our review aims to analyze the evidence for its use in the treatment of various dermatological, neurological, gastroenterological, ophthalmological, otorhinolaryngological, dental, urological, gynecological, and cardiovascular disorders. Methods: A systematic review of the literature was performed for studies published between 2012 and 2022 that discussed the therapeutic use of BoNT in human participants. A total of 58 studies were selected for inclusion in this review. Results: We discovered a large range of therapeutic applications of BoNT toxin beyond aesthetic and US Food and Drug Administration (FDA)-approved non-aesthetic uses. Conclusions: BoNT is a powerful neurotoxin that has varied FDA-approved indications and has been studied in a wide range of therapeutic applications. Further investigation through higher power studies is needed to assess the potential of BoNT and expand its versatility across other medical specialties. J Drugs Dermatol. 2023;22(9): doi:10.36849/JDD.7243e. |
| المشرفين على المادة: | EC 3.4.24.69 (Botulinum Toxins) 0 (Neurotoxins) |
| تواريخ الأحداث: | Date Created: 20230908 Date Completed: 20230919 Latest Revision: 20230919 |
| رمز التحديث: | 20231215 |
| DOI: | 10.36849/JDD.7243e |
| PMID: | 37683072 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1545-9616 |
|---|---|
| DOI: | 10.36849/JDD.7243e |